SCHEMBL6645907

SCHEMBL6645907

CN(C)CC(O)COc1ccc(Nc2ncc(N)c(Nc3ccccc3)n2)cc1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 20/20 0.80
CDK2 P24941 17/20 0.80
CDK1 P06493 1/20 0.51
CCNE1 P24864 1/20 0.51
DAPK3 O43293 1/20 0.49
JAK2 O60674 1/20 0.49
PRKD3 O94806 1/20 0.49
MAP4K4 O95819 1/20 0.49
PAK4 O96013 1/20 0.49
ABL1 P00519 1/20 0.49
LCK P06239 1/20 0.49
FYN P06241 1/20 0.49
CSF1R P07333 1/20 0.49
IGF1R P08069 1/20 0.49
PDGFRB P09619 1/20 0.49
FGFR1 P11362 1/20 0.49
PDGFRA P16234 1/20 0.49
PRKACA P17612 1/20 0.49
LTK P29376 1/20 0.49
KDR P35968 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5581900 0.88 CDK4 (1.00) CDK4CDK2IGF1R
SCHEMBL14632119 0.88 CDK4 (1.00) CDK4CDK2CCNE1DAPK3JAK2
SCHEMBL29644990 0.88 CDK4 (1.00) CDK4CDK2IGF1R
SCHEMBL29644986 0.88 CDK4 (1.00) CDK4CDK2IGF1R
SCHEMBL7239268 0.87 CDK4 (0.78) CDK4CDK2CDK1CCNE1
SCHEMBL7238706 0.86 CDK4 (0.79) CDK4CDK2CDK1CCNE1DAPK3
SCHEMBL6646426 0.84 CDK4 (0.73) CDK4CDK2
SCHEMBL6644644 0.84 CDK4 (0.75) CDK4CDK2CDK1CCNE1DAPK3
SCHEMBL6643501 0.83 CDK4 (0.69) CDK4CDK2CDK1CCNE1DAPK3
Hydrochloric Acid SCHEMBL7232203 0.83 CDK4 (0.73) CDK4CDK2CDK1CCNE1DAPK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140860-B1 PYRIMIDINE COMPOUNDS ASTRAZENECA AB (SE) 2004-09-22 EP disclosed
US-6593326-B1 Useful as anti-cancer agents; and processes for their manufacture and pharmaceutical compositions containing them are described. Apoptotic effect in a warm-blooded animal such as man. ASTRAZENECA AB (SE) 2003-07-15 US disclosed
EP-1140860-A1 PYRIMIDINE COMPOUNDS AstraZeneca AB (SE) 2001-10-10 EP disclosed
WO-2000039101-A1 PYRIMIDINE COMPOUNDS ASTRAZENECA AB (SE) 2000-07-06 WO disclosed